EUVIMEDEUVIMED entdecken
Multizentrische Studie

Impact of health system specialty pharmacies on total cost of care in cancer treatment, a multisite review

Scott Wink, Bridgette Kanz Schroader iD, Toni Giglio, Angela Ward

Journal of Oncology Pharmacy Practice · 2024

DOI: 10.1177/10781552231190016 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Oncology Pharmacy Practice, 2024. Verfasst von Scott Wink und 3 weiteren Autor:innen. Beteiligte Einrichtung: AmerisourceBergen Integrated Health Systems Outcomes Coalition (IHOC), Conshohocken, PA, USA. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 12 Literaturangaben. Gefördert von: AmerisourceBergen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Integrated delivery networks can use medically integrated dispensing of oral oncolytics on site through health system specialty pharmacies. There is little published research examining cost savings. Our objective was to demonstrate the financial value of health system specialty pharmacies among patients receiving oral oncolytics dispensed through fully, partially, and non-integrated dispensing strategies.

Methods

This was a retrospective cohort study of adult patients from Symphony Health's Integrated Dataverse ® repository who filled a prescription for an agent of interest from 7/1/16–6/30/20 that was written within 25 US health systems. Outcomes included costs, healthcare resource utilization, and duration of therapy.

Results

In total, 36,816 patients were included; 986 patients (2.7%) integrated, 1,822 (4.9%) partially integrated, and 34,008 (92.4%) non-integrated. Mean 6-month medical charge and oncolytic prescription costs were lower for the integrated group ($36,831; $55,786) than the partially integrated ($46,304, p = 0.053; $63,295, p = 0.071) and non-integrated groups ($54,261, p < 0.001; $65,005, p = 0.004). In most healthcare resource utilization categories, the integrated group had the lowest patient percentage utilizing medical care. Duration of therapy was lower on average by ∼3 months in the integrated vs non-integrated group, which may represent closer monitoring of patient medical records and need for fills vs autoship practices.

Conclusions

Patients receiving oral oncolytics through medically integrated dispensing at health system specialty pharmacies may have lower medical and pharmacy costs and decreased healthcare resource utilization. This study adds to the growing body of literature supporting integrated delivery networks and integrated dispensing. Further research is needed to demonstrate the value of medically integrated dispensing through health system specialty pharmacies in the delivery of treatment to patients with cancer and other high-cost diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsHumansRetrospective StudiesMaleFemaleMiddle AgedAntineoplastic AgentsAgedUnited StatesHealth Care CostsPharmaciesCost SavingsAdultCohort Studies

Stichwörter der Autor:innen

Health system specialty pharmacycancerhealthcare costsintegrated dispensing

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • AmerisourceBergen Integrated Health Systems Outcomes Coalition (IHOC), Conshohocken, PA, USA.
  • Xcenda LLC, Conshohocken, PA, USA.

ORCID-Profile: Bridgette Kanz Schroader

Förderung

  • AmerisourceBergen

Zitieren

APA

Wink, S., Schroader, B. K., Giglio, T., & Ward, A. (2024). Impact of health system specialty pharmacies on total cost of care in cancer treatment, a multisite review. Journal of Oncology Pharmacy Practice. https://doi.org/10.1177/10781552231190016

Vancouver

Wink S, Schroader BK, Giglio T, Ward A. Impact of health system specialty pharmacies on total cost of care in cancer treatment, a multisite review. Journal of Oncology Pharmacy Practice. 2024. doi:10.1177/10781552231190016

BibTeX
@article{Wink2024,
  author = {Wink, Scott and Schroader, Bridgette Kanz and Giglio, Toni and Ward, Angela},
  title = {Impact of health system specialty pharmacies on total cost of care in cancer treatment, a multisite review},
  journal = {Journal of Oncology Pharmacy Practice},
  year = {2024},
  doi = {10.1177/10781552231190016}
}
Kostenlos starten →